Clinical Study

Aquedeon Medical has received FDA approval to conduct a clinical trial of the Duett Vascular Graft System under an Investigational Device Exemption (IDE). The purpose of the trial is to evaluate the safety and effectiveness of the Duett Vascular Graft System when functioning as a vascular connector to create the anastomosis between one or two native aortic arch vessels and a vascular prosthesis (graft) during open surgical aortic arch reconstruction. More information regarding the Duett Vascular Graft System clinical trial can be found at: https://clinicaltrials.gov/ct2/show/NCT06253143. Should you require further information regarding the Duett Vascular Graft System clinical trial, contact Aquedeon Medical utilizing the contact page on this website..